• Nivolumab prior to surgery appears safe, effective in metastatic renal cell carcinoma

    5 monthes ago - By Healio

    CHICAGO - Nivolumab plus or minus bevacizumab or ipilimumab prior to surgery appeared safe and demonstrated promising clinical activities in patients with metastatic renal cell carcinoma, according to study results presented at ASCO Annual Meeting.
    Jianjun Gao, MD, PhD, an assistant professor in the department of genitourinary medical oncology at The University of Texas MD Anderson Cancer Center, and colleagues conducted an open-label, randomized, pre-surgical trial of adults with metastatic renal cell carcinoma to determine if the combination of nivolumab
    Read more ...